SCHEMBL8909655

SCHEMBL8909655

[CH2]C(c1cccnc1)C1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.47
CYP2D6 P10635 4/20 0.46
CYP2C19 P33261 4/20 0.46
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 2/20 0.46
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
CFTR P13569 1/20 0.43
GOPC Q9HD26 1/20 0.43
ALDH1A1 P00352 4/20 0.42
CYP2C9 P11712 2/20 0.42
TSHR P16473 2/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
POLB P06746 2/20 0.40
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3686055 0.81 CYP11B2 (0.49) CYP11B2CYP2D6CYP2C19CYP3A4CYP1A2
SCHEMBL7407401 0.79 CYP11B2 (0.44) CYP11B2CYP2D6CYP2C19CYP3A4CYP1A2
SCHEMBL8910330 0.78 CYP19A1 (0.41) CYP11B2CYP2D6CYP2C19CYP3A4CYP1A2
SCHEMBL57120 0.77 IDO1 (0.53) KDM4EPKMMEN1KMT2AMAPT
SCHEMBL22003589 0.77 CYP11B2 (0.45) CYP11B2CYP2D6CYP2C19CYP3A4CYP1A2
SCHEMBL8909681 0.76 CYP11B2 (0.44) CYP11B2CYP2D6CYP2C19CYP3A4CYP1A2
SCHEMBL497969 0.75 IDO1 (0.50) OPRM1OPRD1PKMMEN1KMT2A
SCHEMBL19310680 0.75 SLC6A4 (0.46) CYP11B2CYP2D6CYP2C19CYP3A4CYP1A2
SCHEMBL4238433 0.73 SLC6A3 (0.49) CYP11B2CYP2D6CYP2C19CYP3A4CYP1A2
SCHEMBL10983034 0.73 GAA (0.65) CYP11B2CYP2D6CYP2C19CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5622953-A DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG BASF AKTIENGESELLSCHAFT (DE) 1997-04-22 US disclosed
EP-0691962-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1996-01-17 EP disclosed
WO-1994022842-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1994-10-13 WO disclosed